13F HOLDINGS REPORT
Sands Capital Ventures, LLC
Quarter ended Q2 2025 · Filed August 13, 2025 · Accession 0001020066-25-000029
Total Value
$507.8M
Positions
20
Other Managers
0
Confidential Omitted
No
Holdings (19)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | KLAVIYO INC | KVYO | 3,515,065 | $118.0M | 23.24% |
| 2 | NU HLDGS LTD | NU | 7,175,434 | $98.4M | 19.39% |
| 3 | DOORDASH INC | DASH | 381,202 | $94.0M | 18.50% |
| 4 | BETA BIONICS INC | BBNX | 3,570,113 | $52.0M | 10.24% |
| 5 | COUPANG INC | CPNG | 849,031 | $25.4M | 5.01% |
| 6 | INHIBIKASE THERAPEUTICS INC | IKT | 10,950,000 | $21.4M | 4.20% |
| 7 | MONDAY COM LTD | MNDY | 58,336 | $18.3M | 3.61% |
| 8 | SAMSARA INC | IOT | 438,485 | $17.4M | 3.43% |
| 9 | DATADOG INC | DDOG | 118,707 | $15.9M | 3.14% |
| 10 | CROWDSTRIKE HLDGS INC | CRWD | 15,615 | $8.0M | 1.57% |
| 11 | TOAST INC | TOST | 156,604 | $6.9M | 1.37% |
| 12 | TARSUS PHARMACEUTICALS INC | TARS | 170,000 | $6.9M | 1.36% |
| 13 | SNOWFLAKE INC | SNOW | 27,005 | $6.0M | 1.19% |
| 14 | 10X GENOMICS INC | TXG | 481,770 | $5.6M | 1.10% |
| 15 | ACUMEN PHARMACEUTICALS INC | ABOS | 3,417,075 | $4.0M | 0.78% |
| 16 | BIOAGE LABS INC | BIOA | 786,353 | $3.2M | 0.64% |
| 17 | ACRIVON THERAPEUTICS INC | ACRV | 2,122,605 | $2.5M | 0.50% |
| 18 | CANDEL THERAPEUTICS INC | CADL | 405,837 | $2.1M | 0.40% |
| 19 | TAYSHA GENE THERAPIES INC | TSHA | 724,873 | $1.7M | 0.33% |